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a b s t r a c t
Endoscopic ultrasound (EUS)-guided transmural drainage has evolved as an important treatment modality for peripancreatic ﬂuid collections (PFCs).
Recently, self-expandable metal stents (SEMS) have been introduced as an alternative for the traditionally used double-pigtail plastic stents, for endo-
scopic drainage. Due to the larger diameter (>10 mm) of SEMS, a wide drainage opening can be created, with a potentially reduced risk of stent occlusion
and associated complications, and a direct access route if endoscopic necrosectomy is indicated. The use of different types of SEMS has been reported in
several case reports and small case series. Although the results of these studies seem promising, the available results to date are limited and need critical
appraisal. Large prospective and randomized trials are needed to evaluate the efﬁcacy and safety of the placement of SEMS for endoscopic drainage of
PFCs.
Copyright  2013, Society of Gastrointestinal Intervention. Published by Elsevier.
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Peripancreatic ﬂuid collections (PFCs) may complicate the
course of acute and chronic pancreatitis, pancreatic surgery or
trauma. They develop due to disruption of the pancreatic duct,
with subsequent ﬂuid leakage, or as a consequence of maturation
of (peri)pancreatic necrosis.13 Over the past decade, endoscopic
ultrasound (EUS)-guided transmural drainage has evolved as an
important treatment modality for PFCs.4
The aim of this review is to give an overview of EUS-guided
treatment modalities for the different types of PFCs, with special
focus on the use of self-expandable metal stents (SEMS).
Deﬁnitions of peripancreatic ﬂuid collections
The use of precise terminology and strict deﬁnitions for different
types of PFCs is important, since each form requires a distinct
treatment strategy. Moreover, a universal classiﬁcation system is
essential for comparing results of studies. In 1992, the widely
accepted Atlanta Classiﬁcation was introduced as a clinically based
classiﬁcation system for PFCs that occur as a complication of acute
pancreatitis.1 Deﬁnitions were proposed for the following types of
collections: acute ﬂuid collection, pseudocyst, pancreatic abscess
and pancreatic necrosis. In order to describe the evolution of
pancreatic necrosis and acute ﬂuid collections to a more organized,Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrech
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the term, organized pancreatic necrosis, in 1996.2 Although this
term for describing PFCs was not deﬁned in the 1992 Atlanta
Classiﬁcation, it has been widely adopted from then on.5
The original Atlanta Classiﬁcation is considered to be a mile-
stone in the classiﬁcation of PFCs. Nonetheless, new insights into
the pathophysiology of acute pancreatitis, improved imaging
techniques, and the emergence of minimally invasive techniques
for themanagement of PFCs, made it necessary to revise the Atlanta
Classiﬁcation in 2008 (Table 1).6,7 In the revised Atlanta Classiﬁ-
cation, PFCs were deﬁned by the presence or absence of necrosis.
This distinction between ﬂuid and nonliqueﬁed collections is
important, as the therapeutic strategy and clinical outcome differ
between collections containing ﬂuid alone and those containing
necrotic debris as well. Subsequently, collections were further
subdivided according to whether the contents are infected or
sterile.8–11
Acute collections, developing within the ﬁrst 4 weeks after the
onset of acute pancreatitis, are referred to as either acute peri-
pancreatic ﬂuid collections (APFC) or as acute necrotic collections
(ANC). APFCs are extrapancreatic homogeneous collections without
nonliqueﬁed components, i.e., debris or necrosis, and lack a well-
deﬁned wall. The majority of these APFCs are reabsorbed sponta-
neously within several weeks and only a minority matures into a
pancreatic pseudocyst (PP). Drainage is only indicated in the raret, The Netherlands
Medical Center Utrecht, P.O. Box 85500, 3508 GA Utrecht, The Netherlands.
vier. Open access under CC BY-NC-ND license.
Table 1 Comparison of Atlanta Classiﬁcation 1992 and Revised Atlanta Classi-
ﬁcation 2008
Atlanta Classiﬁcation – 1992 Working Group Classiﬁcation – 2008
<4 wk after onset of acute pancreatitis
Acute ﬂuid collection Acute peripancreatic ﬂuid collections (APFC)
Sterile
Infected
Pancreatic necrosis Acute necrotic collection (ANC)
Sterile
Infected
4 wk after onset of acute pancreatitis
Pancreatic pseudocyst (PP)
Pancreatic pseudocyst Sterile
Pancreatic abscess Infected
Organized pancreatic necrosis* Walled-off pancreatic necrosis (WOPN)
Sterile
Infected
* Introduced by Baron et al. (1996).
Daisy Walter et al. / SEMS for transmural drainage 25case that an APFC becomes infected.7,12 In contrast, ANCs contain
both ﬂuid and necrotic material in various proportions, due to
gradual liquefaction of necrotic tissue. These collections are not
encapsulated and infected necrosis in these collections is an indi-
cation for drainage.7,11
Within a period of approximately 4 weeks, acute collections
mature and become encapsulated. These mature collections are
subdivided into a PP and walled-off pancreatic necrosis (WOPN).
PPs are deﬁned as homogeneous ﬂuid collections surrounded by a
well-deﬁned nonepithelialized ﬁbrous wall, without nonliqueﬁed
components. They usually contain increased amylase and lipase
levels, due to communication with the pancreatic ductal system.
Sealing of such ductal disruptions explains the spontaneous reso-
lution of the majority of PPs. Intervention is only indicated for PPs
causing pain, jaundice or gastric outlet obstruction, due to
compression on the biliary or gastrointestinal tract or fever due to
infection.13–15
WOPN represents the late stage of an AFPC, previously referred
to as organized pancreatic necrosis.2 A thickened wall, without an
epithelial lining, forms the interface between necrosis and adjacent
viable tissue. Infected WOPN usually require drainage to effectively
control sepsis, whereas in patients with sterile WOPN, the need for
drainage is based on the same symptoms as for a PP.7,12,13
Treatment modalities
Themanagement of PFCs has changed considerably over the last
decades. Until the introduction of endoscopic drainage of PFCs in
the late 1980s, treatment options were limited to surgical and
percutaneous drainage. Since then, endoscopic transmural
drainage has emerged as an important minimally invasive treat-
ment modality.4,16,17
Surgical drainage
Surgery of PP involves internal drainage by creating an anas-
tomosis between the cyst and a small-bowel loop, a cyst-enteric
anastomosis. Although success rates are excellent, the procedure
is associated with signiﬁcant morbidity and mortality rates of
24% and 5.8%, respectively.18,19 Furthermore, surgical drainage
of PP is associated with a longer hospital stay compared to
EUS-guided drainage.20 The main role of surgical drainage for PP
is, therefore, adjunctive to an endoscopic procedure or as salvage
therapy.4
The traditional surgical approach for WOPN is an open surgical
necrosectomy. This invasive procedure is associated with high
morbidity (34–95%) and mortality (11–39%) rates.21 Minimallyinvasive surgical techniques, including laparoscopic necrosectomy
and video-assisted retroperitoneal debridement (VARD), have
gained wide popularity as alternatives due to lower morbidity and
mortality rates (25–88% and 0–25%, respectively).21,22 A recent
randomized pilot study, comparing surgical necrosectomy to
endoscopic necrosectomy, showed a higher pro-inﬂammatory
response as well as higher morbidity and mortality rates for the
surgical approach in cases of infected necrosis.23 Despite these re-
sults, to date, surgical necrosectomy still has an important role in
the step-up treatment algorithm for WOPN.21,24
Percutaneous drainage
A less invasive alternative to surgery is percutaneous drainage,
performed under radiological guidance. Although clear ﬂuids can
be drained effectively via the percutaneous drain, a drawback of
this technique is the inability to clear the necrotic content from the
cyst.4 In approximately half of patients with infected WOPN,
drainage of the infected ﬂuid provides adequate control of sepsis
and the necrotic material will be reabsorbed without formal
necrosectomy. However, additional necrosectomy is needed in the
other patients.21,24–27 Risks associated with percutaneous drainage
include puncture of adjacent viscera, secondary infection and
bleeding. Furthermore, a prolonged need for an external draining
catheter may result in a considerable risk of developing a pan-
creaticocutaneous ﬁstula. For collections which cannot be accessed
endoscopically, or those without a mature wall, percutaneous
drainage may be of additive value.4,26
Endoscopic drainage
As mentioned above, endoscopic transmural drainage of PPs
was introduced in the 1980s.16,17 The ﬁrst endoscopic necrosectomy
for WOPN followed in 1996, by Baron et al.2 Since the ﬁrst reports,
muchmore experience has been gained and endoscopic techniques
have evolved. Endoscopic drainage entails the creation of a ﬁstu-
lous tract between the PFC and the lumen of the upper gastroin-
testinal tract, followed by placement of double-pigtail stents and
eventually a nasocystic catheter to facilitate drainage. To be eligible
for this approach, PFCs should have a well-deﬁned wall and be
located within 1 cm of the duodenal, esophageal or gastric wall.
Furthermore, the presence of a luminal bulge is a prerequisite when
performing endoscopic drainage without EUS-guidance, since this
is a relatively blind approach. Due to direct sonographic visualiza-
tion, the introduction of EUS-guidance enables drainage of non-
bulging PFCs, without an increased risk of perforation or puncture
of other organs. Moreover, intervening vessels can be identiﬁed by
using Doppler ultrasound and avoided at the puncture site, with a
potential reduction of the bleeding risk.4,28 Apart from access and
safety, performing EUS before endoscopic drainage can provide
essential information to rule out alternative diagnoses and differ-
entiate between WOPN and PPs.29,30
Two randomized trials have compared endoscopy-guided, with
EUS-guided, drainage for PPs. In the EUS-guided group, fewer
complications were reported; however, this difference was not
statistically signiﬁcant. The technical success rates were signiﬁ-
cantly higher for EUS-guided drainage (94–100%) than for endos-
copy-guided drainage (33–72%) (P < 0.05). This difference was
mainly due to a high failure rate for nonbulging PP in the endoscopy
group.31,32 Although some other studies have reported technical
success rates to be equal for both endoscopy-guided and EUS-
guided drainage, EUS-guidance is increasingly being used for
drainage.28,33
The success rate of EUS-guided drainage is highly dependent on
the type of PFC drained. The use of different nomenclature, leads to
Table 2 EUS-guided Drainage of Peripancreatic Fluid Collections (PFC) Using Self-expandable Metal Stents (SEMS)
Authors No. Type of stent Stent
lumen (mm)
Type of
collection (n)
Technical
success (%)
Puncture
site (n)*
Clinical
success n (%)
Complications (n)
Fully covered biliary SEMS
Talreja et al (2008)43 18 VIABIL 10 PFC 94% – 17 (94%) Bleeding (2)
Stent migration (1)
Superinfection (5)
Tarantino et al (2009)37 1 Wallstent 10 WOPN 100% TD 1 (100%) –
Fabbri et al (2012)38 20 WallFlex/Niti-S 10 Abscess (6)
Infected PP (12)
Infected WOPN (2)
100% TG (12)
TD (6)
TG þ TD (2)
19 (95%) Superinfection (2)
Stent migration (1)
Surgical stent removal (1)
Berzosa et al (2012)39 7 VIABIL 10 PP (5)
WOPN (2)
100% TG 7 (100%) –
Tarantino et al (2012)42 1 Taewoong 8 PP 100% TG þ TD 1 (100%) –
Penn et al (2012)40 20 WallFlex 10 PP (20) 100% TG 17 (85%) Stent migration (3)
Superinfection (2)
Post-drainage fever (1)
Weilert et al (2012)41 18 WallFlex 10 Abscess (8)
Acute collection (7)
PP (3)
100% – 14 (78%) Superinfection (3)
Partially covered biliary SEMS
Barresi et al (2012)44 1 Wallstent 10 PP 100% TG 1 (100%) Surgical stent removal (1)
Nici et al (2012)45 1 WallFlex 10 PP 100% TG 1 (100%) –
Other SEMS
Antillon et al (2009)47 1 Alimaxx-E Esophagus 22 Infected WOPN 100% TG 1 (100%) –
Belle et al (2010)48 4 Leufen 18–25 Infected WOPN (4) 100% TG (3)
TD (1)
1 (100%) –
Perez-Miranda et al (2007)46 4 Hanaro tracheal (2)
Hanaro enteral (2)
15–18 Abscess (1)
WOPN (3)
100% TG 3 (75%) Piece-meal stent removal (1)
Transmural SEMS
Itoi et al (2012)49 15 AXIOS 15 PP (15) 100% TG (12)
TD (3)
15 (100%) Stent migration (1)
Oozing at stent removal (3)
Itoi et al (2012)50 1 NAGI 16 Infected WOPN 100% TG 1 (100%) –
Total 112 8–25 111/112 (99%) 99/112 (88%)
PP, pancreatic pseudocyst; TD, transduodenal; TG, transgastric; WOPN, walled-off pancreatic necrosis.
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Daisy Walter et al. / SEMS for transmural drainage 27a direct comparison of studies not always being easy, although it is
clear that adequate treatment of WOPN is much more challenging
than draining PPs.8,9 In larger series, the technical success rate of
EUS-guided drainage of PPs ranges from 90% to 100%. Treatment
success, deﬁned as clinical improvement or complete resolution on
imaging, is observed in >90% of patients. Complication rates range
from 0% to 31%, and include bleeding, infection, pneumo-
peritoneum and stent-related complications, such as stent migra-
tion or occlusion.4
The need for necrosectomy in addition to drainage alone, in
most cases of (infected) WOPN, makes the treatment of this type of
PFC more challenging. For endoscopic drainage alone, success rates
as low as 25% have been reported.4 A much higher resolution rate
(76%) has been reported for WOPN treated with endoscopic
necrosectomy. Furthermore, with a mortality rate of 5% and a
morbidity rate of 30%, this can be considered as a relatively safe
procedure.34
SEMS
To further improve endoscopic treatment of PFCs, SEMS have
recently been used as an alternative for the traditionally used
double-pigtail stents (Table 2). The use of plastic pigtail stents is
limited by the small diameter of the stent lumen (7–10F). Several
studies have shown that placement of multiple stents ensures a
wider drainage opening, with a low risk of obstruction of the ﬁstula
tract, resulting in better clinical success rates. Furthermore, there is
a reduced risk of stent migration, which also reduces the risk of
premature closure of the ﬁstula tract.35,36 Since SEMS have a larger
diameter (>10 mm), placement of a single SEMS can already pro-
vide a wide drainage opening. Furthermore, due to the larger stent
lumen, there is a reduced risk of stent occlusion, especially for
collections containing a signiﬁcant amount of debris. As a result,
complications due to stent occlusion, for example, infection of the
PFC, are expected to be reduced. Lastly, SEMS can provide an
enduring direct access route for endoscopic transmural necrosec-
tomy. The use of different types of SEMS has been described in
several case reports and small case series.
Biliary SEMS
Fully covered biliary SEMS with a 10 mm diameter, are the most
frequently used SEMS for endoscopic drainage of PFCs. Experience
with this type of stent has been reported in seven reports
comprising 85 patients with PFCs.37–43 All but two stent place-
ments were performed under EUS-guidance and placement failed
in one patient. To prevent migration of the fully covered stents,
plastic pigtail stents were placed through or alongside the SEMS in
38 patients40,43 and a plastic stent with ﬂaps was placed through
the stent in one patient.42 Stent migration was reported in four
(10%) patients with an anchoring stent to prevent migration,
whereas only one (3%) stent migration was reported in patients
without additional stents. Clinical success, deﬁned as complete
resolution of symptoms and resolution on imaging, was achieved in
76 of 85 patients (89%).37–42 In ﬁve of these, endoscopic necrostomy
was performed before resolution was achieved. The SEMS was
removed before necrosectomy and replaced by plastic pigtails after
the procedure.41 Surgery was required in the other patients to
effectively control sepsis.38,40,41,43 In one patient, endoscopic stent
removal was not possible due to inﬂammatory tissue ingrowth, and
surgical removal was indicated.38
The use of partially covered biliary SEMS has been reported in
two case reports.44,45 Tissue ingrowth in the uncovered stent end
was thought to reduce the risk of migration in these stents. How-
ever, severe tissue ingrowth may cause problems during stentremoval. Barresi et al reported this as early as 1 month after
placement of the SEMS. The stent was embedded in the gastric wall
and completely covered by gastric mucosa, which was described as
a buried stent. The stent was removed through a surgical proce-
dure.44 Nici et al did not experience any problems with removal of
the partially covered SEMS 3 weeks after placement.45
Other SEMS
To provide an even wider drainage opening than with biliary
SEMS, other types of SEMS have been used for PFC drainage. Perez-
Miranda et al report on the use of a 15-mm covered tracheal SEMS
(n ¼ 2) and a 18-mm covered enteral SEMS (n ¼ 2) for EUS-guided
drainage of PFCs. Double pig-tail stents, and/or a nasocystic drain,
were placed through the stent to reduce migration risk, although
one stent migration was reported. Endoscopic irrigation and
necrosectomy was performed through the lumen of the SEMS.
Clinical success was seen in three of four patients (75%) while in
one patient, the stent had to be removed in a piece-meal way.46 A
22-mm esophageal SEMS with ﬂared ends was used by Antillon at
al to facilitate drainage in one patient. Previously placed double-
pigtail plastic stents and a nasocystic drain were left in place
alongside. With ongoing irrigation, symptom resolution was ach-
ieved within 2 weeks and all stents could easily be removed.47 Belle
et al reported their experiences with specially designed 18-mm to
25-mm partially covered SEMS in four patients. Subsequent
endoscopic procedures, including necrosectomy and lavage, were
performed through the stent. Resolution of symptoms was ach-
ieved in all patients and the partially covered SEMS were easily
removed.48
Dedicated transmural stents
To overcome the limitations associated with the use of tubular
SEMS for transmural drainage, such as migration and tissue
ingrowth, novel drainage SEMS have been developed. Both the
AXIOS stent (Xlumena Inc, Mountain View, CA, USA) and the NAGI
stent (Taewoong Company, Seoul, Korea) are speciﬁcally developed
for transmural drainage (Fig. 1). They both have a saddle-shape
design, with bilateral ﬂanges, and a stent length between those
ﬂanges of 10-mm and 20-mm, respectively. The ﬂanges are
designed to provide lumen-to-lumen anchoring, thereby reducing
the risk of migration and leakage alongside the stent. Furthermore,
both stents are fully covered to prevent tissue ingrowth and to
enable easy removal. The diameter of the stents, 10-mm or 15-mm
for the AXIOS stent and 16-mm for the NAGI-stent, enables direct
necrosectomy through the lumen of the stent.
Itoi et al49 retrospectively reported on the use of the AXIOS stent
in 15 patients with symptomatic PFCs. Stents were successfully
placed in all patients and the stents were used as access portals for
a diagnostic endoscope (<10 mm) to perform necrosectomy and
irrigation. Dislodgement or removal of the stent during these in-
terventions was not observed. However, stent migration to the
stomach was reported in one patient. The cystogastrostomy tract in
this patient was dilated up to 15-mm before placement of a 10-mm
stent, which might be an explanation for migration. Resolution of
the PFCs was achieved in all patients and stents could be removed
without complications.
The experiencewith the NAGI stent is limited to one case report,
for drainage of an infected WOPN, also by Itoi et al.50 Stent place-
ment was performed using a transgastric approach. Necrosectomy
was performed during two subsequent endoscopy sessions,
whereby a standard upper endoscope was inserted through the
stent. No complications were reported and the stent was easily
removed after 3 weeks.
Fig. 1. Dedicated transmural stents: the AXIOS-stent (Xlumena Inc, Mountain View, CA, USA) and the NAGI-stent (Taewoong Company, Seoul, Korea).
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The use of SEMS for EUS-guided drainage of PFCs seems
promising, based on the overall clinical success rate of 88% and only
one placement failure in the above mentioned studies. However,
the available results to date are limited and need critical appraisal.
First, theuseofSEMShasbeenreported fordrainageofbothWOPN,
containing signiﬁcant amounts of necrotic debris, as well as for PPs.
However, as for drainage of PPs with plastic stents, excellent clinical
success rateshavebeen reported, it remains tobeestablishedwhether
the use of SEMS has any added clinical value for this indication.
Second, the use of SEMS is, in many cases, probably not cost-
effective, as they are far more expensive than plastic stents. It is
thought, however, that the higher initial costs for SEMS will be
offset by a reduction in the number of repeat endoscopies. This
reductionwill than probably be more distinctive forWOPN than for
PPs. However, the number of repeat endoscopies is difﬁcult to
compare, since in some studies, necrosectomy and irrigation was
performed at preset moments, whereas in other studies, repeat
endoscopy was only performed based on clinical symptoms.
Third, awide variety of SEMS is currently available. Fully covered
SEMS are the most commonly used stents, mainly since they have
the lowest risk of tissue ingrowth. To prevent migration of the
stent, some preventative measures can be used, including place-
ment of double pigtail plastic stents in or alongside the stent, the
use of stents with bilateral ﬂares, or not performing dilation before
stent placement. Also, partially covered SEMS have been used, as
they are less prone to migration, which is thought to be due to
tissue ingrowth at the uncovered stent ends. However, hyperplastic
tissue ingrowth can also lead to signiﬁcant problems during
endoscopic removal, and in some cases, surgery is required.44 In
order to prevent tissue ingrowth as well as migration, dedicated
SEMS for transmural drainage have been developed. However, even
with these devices, stent migration has been reported as well.49
Last, the studies that have been published on the use of SEMS for
PFC drainage all have limitations, such as the inclusion of small
numbers of patients, the lack of a control group, the use of different
stent designs, the absence of preset endpoints, no long-term
follow-up results, a retrospective design, etc. Well designed pro-
spective studies and randomized trials are therefore needed to
validate the initial promising results on the use of SEMS for endo-
scopic drainage of PFCs. A comparison should be made with con-
ventional drainage using plastic stents and also a clear distinction
should be made for the different types of PFCs, using well estab-
lished criteria. Apart from the efﬁcacy and safety, a cost analysis
should be performed to elucidate whether the more expensive
SEMS are indeed cost-effective, as compared to plastic stents, when
used for the drainage of PFCs.Conﬂicts of interest
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